Atlantic Sapphire ASA 2025 IR
The report highlights Atlantic Sapphire's operational recovery and biological performance improvements at its U.S. Bluehouse facility in 2025. The company achieved its strongest biological results to date, characterized by lower mortality rates of 1.65% and increasing harvest weights. Key infrastructure upgrades in water treatment, cooling, and filtration were implemented to enhance reliability and prepare for future scalability. Additionally, the company fully integrated in-house fillet production and raised USD 35.4 million in new funding through a convertible loan to support ongoing operations.
Company: Atlantic Sapphire ASA
Sector: Consumer Staples
Country: Norway
Year: 2025
Type: IR
Pages: 203
Atlantic Sapphire ASA
Annual Report
The report highlights Atlantic Sapphire's operational recovery and biological performance improvements at its U.S. Bluehouse facility in 2025. The company achieved its strongest biological results to date, characterized by lower mortality rates of 1.65% and increasing harvest weights. Key infrastructure upgrades in water treatment, cooling, and filtration were implemented to enhance reliability and prepare for future scalability. Additionally, the company fully integrated in-house fillet production and raised USD 35.4 million in new funding through a convertible loan to support ongoing operations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Energy Consumption
Renewable Energy
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees